普雷克萨斯 PLXS 深 沪
等待开盘 02-05 09:30:00 美东时间
196.28
-7.500
-3.68%
华盛通- 最 高207.06
- 今 开204.09
- 成交量 70.01万股
- 最 低 193.49
- 昨 收 203.78
- 总市值 52.55亿
- 52周最高 208.92
- 市盈率 静 31.35
- 换手率 2.61%
- 52周最低 103.43
- 委 比 0.00%
- 总股本 2677.44万
- 历史最高 208.92
- 量 比 1.27
- 振 幅 6.66%
- 历史最低 19.63
- 每 手 1
- 风险率 14.99%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多5 Stock Picks Last Week From Wall Street's Most Accurate Analysts
U.S. stocks settled lower on Friday, with the Nasdaq Composite falling more tha...
02-02 20:02
美股大行评级 | 苹果、SanDisk、西部数据、卡特彼勒、德克斯户外、霍尼韦尔、西南航空、万事达等获多家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Praxis Precision Medicine"买入"评级，目标价从340美元升至1245美元；HC Wainwright & Co.：维持Perspective Therapeutics"买入"评级，目标价从10美元升至12美元
02-02 14:15
Plexus Corporation Publishes Q1 2026 Earnings Call Transcript
Plexus Corporation Publishes Q1 2026 Earnings Call Transcript Plexus Corporation has published the transcript of its Q1 2026 earnings call, providing insights into the company’s performance and strategic direction as it marks its 40th year as a publicly traded firm. The call, held on January 29, 202
01-31 04:19
What Analysts Are Saying About Plexus Stock
Providing a diverse range of perspectives from bullish to bearish, 5 analysts h...
01-31 04:00
U.S. RESEARCH ROUNDUP-Definium Therapeutics, Kenvue, Werner Enterprises
U.S. RESEARCH ROUNDUP-Definium Therapeutics, Kenvue, Werner Enterprises Jan 30 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Definium Therapeutics, Kenvue and Werner Enterprises on Friday. HIGHLIGHTS * Ameriprise Finan
01-30 15:45
美股大行评级 | Meta 、IBM、拉姆研究、布林克国际等获多家机构上调目标价；微软、特斯拉、ServiceNow、自动数据处理等遭多家下调评级
今日重点评级关注：Piper Sandler：上调Korro Bio评级至"超配"，目标价从11美元升至30美元；Piper Sandler：维持Nurix Therapeutics"超配"评级，目标价从32美元升至35美元
01-30 17:38
财报速睇 | 普雷克萨斯 2026财年Q1营收10.70亿美元，同比增长9.6%；归母净利润0.41亿美元，同比增长10.5%
华盛资讯1月29日讯，普雷克萨斯公布2026财年Q1业绩，公司Q1营收10.70亿美元，同比增长9.6%，归母净利润0.41亿美元，同比增长10.5%。
01-29 15:32
美股大行评级 | 希捷科技、德州仪器、HCA控股、通用汽车、波音、UPS等或多家机构上调目标价；布朗保险、康沃系统、Qorvo、联合健康等遭多家机构下调目标价
今日重点评级关注：Piper Sandler：维持Praxis Precision Medicine"超配"评级，目标价从450美元升至1200美元；Tigress Financial：维持Main International ETF"买入"评级，目标价从52美元升至66美元
01-29 11:06
BRIEF-Plexus Announces Fiscal First Quarter Financial Results
BRIEF-Plexus Announces Fiscal First Quarter Financial Results Jan 28 (Reuters) - Plexus Corp PLXS.O : PLEXUS ANNOUNCES FISCAL FIRST QUARTER FINANCIAL RESULTS Source text: ID:nGNXPHLWm Further company coverage: PLXS.O (( Reuters.Briefs@thomsonreuters.com ;))
01-29 06:30
Electronics manufacturer Plexus meets Q1 revenue expectations
Electronics manufacturer Plexus meets Q1 revenue expectations Overview Manufacturer's fiscal Q1 revenue met analyst expectations, non-GAAP EPS hit high end of guidance Company won 22 manufacturing programs, representing $283 mln in annualized revenue Company repurchased $22.4 mln of shares under 202
01-29 05:27
